Benefits of REPRIEVE
to Minimize Risk
All participants will receive
guidance on steps to improve
heart health, including:
kely to develop
duals without HIV.
Taking antiretroviral
of heart disease therapy
www.reprievetrial.org
Keeping cholesterol,
DA. Statins are usedblood
to pressure,
and blood sugar in
good range
1-877-29-HEART
(1-877-294-3278)
sidered safe for use
imens.
ng well
e with HIV
U ARE:
Not smoking
Eating well
Exercising
Exercising
www.reprievetrial.org
What is REPRIEVE?
Am I eligible?
Why should I participate?
REPRIEVE is a clinical research trial testing whether
a daily dose of a statin medication (pitavastatin)
lowers the risk of heart-related disease among
people living with HIV.
•
HIV-positive between ages 40 and 75
By participating in REPRIEVE, you will be:
•
On antiretroviral therapy (ART) for at least 6
months prior to study entry
•
No history of cardiovascular disease
(including heart attack or stroke)
Helping us understand whether pitavastatin
prevents heart-related disease among people
living with HIV.
•
Not currently using a statin drug
An important goal of the study is to examine how
factors unique to women - such as female hormones
- affect heart disease risk. The study will also teach
us whether pitavastatin lowers heart disease risk in
women as well as it lowers risk in men. Women’s
participation is important.
LENGTH OF PARTICIPATION
48 months on average
SIMPLE TIME COMMITMENT
Visits about
3 times per year
THERE’S A SITE NEAR YOU
Paying it forward, helping to make it possible for
people with HIV to live longer and healthier lives.
Learn more about
the REPRIEVE trial
and how to sign up!
www.reprievetrial.org
1-877-29-HEART
(1-877-294-3278)